INTRODUCTION
Methanol extract of Ludwigia Prostrata root exhibited antitumour activity against Dalton's ascetic Lymphoma (DAL) in swiss albino mice. The enhancement of median survival time by the root extract was significant when compare with control group. White blood cell count was decreased in the treated one with respect to tumour bearing mice.
Ludwigia prostrata Roxb 1 (Neer Kirambu in Tamil) belonging to family onagraceae was not studied for its medicinal properties fully, sofar. Basella alba Linn. of Basellaceae is an ingredient of the drug sukhaprasavada ghrtam 2 some species of Ludwigia are used only as substitute for basella. 3 Present study deals with the antitumour activity of L. prostrata root.
MATERIALS AND METHODS
Roots of the plant were collected at mukkombu, Trichy Dt., Tamilnadu shade dried, powdered and finally extracted with methanol in a soxhlet. The extract was evaporated to dryness and dissolved in phosphate buffer (pH 7.4) and used for the present investigation and phytochemical screening. 
EFFECTOFROOTEXTRACTONSURVI VAL TIME
Animals were inoculated (i.p) with 2 x 10 5 cells/ mouse on day 0, and treatment with root extract started 24 hr after inoculation at a dose of 50mg/kg/day i.p ROUP!), 100 mg/kg/day i.p (group II). The control (group III) was treated with same volume of 0.9% sodium chloride. All treatment were carried out for nine days. The group V animals were treated with standard drug 5-Fluorouracil (5U)) 20 mg/kg/day i.p for 9 days) and median survival times (MST) noted for each group. The animals surviving more tan 60 days were considered to be cured survival time of treated groups were compared with those of control group IV (Treated with 5 FU) using the following formula 4 .
Day of 1st death + Day of last death Median survival time (MST)= 2
MST of treated group Increase in life span (ILS) = T/C % = MST of control group x100 Number of animals used: 10 in each group Days of drug treatment: 9
HAEMATILOGICAL STUDIES
To measure the influence of root extract on the hematological status of DAL bearing mice, comparison was made among five groups (n=5) of mice on the 14 th d after inoculation. The groups are (1) tumour bearing mice (2) tumour bearing mice treated wit root extract (50 mg/kg i.p) for 9 days (3) tumor bearing mice treated with root extract 100 mg/kg/day i.p (4) tumour bearing mice treated wt 5 FU (5) normal mice. Blood was drawn from the tail vein in the conventional was and the red blood cell count, white blood cell count, haemoglobin, protein and packed cellular volume were determine 5, 6 The average of 5 determination was computed.
RESULT
The effect of root extract in different concentrations on the survival of tumour bearing mice showed MST 26 days and 28 days respectively. MST for control group was 21 days and 39 days for the group treated with 5 Fu (20mg/kg/day i.p).
Haematological parameters of (Table II) tumour bearing mice on day 14 were found to be significantly altered from the normal group. Total WBC, protein and P.C.V were found to be increased. The haemoglobin content was also reduced. In the differential count of the WBC, the percentage of lymphocyte count decrease and the neutrophils increased.
When treated with root extract (dose 50 mg) and (dose 100mg) increased the RBC, haemoglobin and lymphocytes. They decreased WBC, protein and P.C.V The curing effect of 5 FU is more than the root extracts.
DISCUSSION pages 179 -182
The curing effect of any anticancer drug is measured by the enhancement of the life span of the animal7 and the reduction in number of white blood cells 8 from the blood. The above result of the experiments, i.e prolongation of life span and reduction in WBC reveal the anticancer effect of the root extract of Ludwigia prostrate. 
